Article
Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer
16 Feb 2006
Abstract excerpt
BACKGROUND: Activated leucocyte cell adhesion molecule (ALCAM, CD166) is a cell surface member of the immunoglobulin superfamily. ALCAM expression has prognostic relevance in prostate and colon cancer. OBJECTIVE: To evaluate ALCAM protein expression in breast cancer by immunohistochemistry and to correlate expression levels with clinicopathological data. METHODS: 162 primary breast carcinomas with a mean clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
